List view / Grid view

Priya Baraniak (OrganaBio)

 

article

The hidden risks of over-reliance on healthy donor material

10 October 2024 | By

Developing cell therapies solely with healthy donor material can jeopardise clinical outcomes, introducing risks ranging from faulty preclinical data to manufacturing failures. We spoke to Priya Baraniak, CBO at OrganaBio, who advocates for early integration of diseased donor material, improved biobanking infrastructure, and cross-industry collaboration to develop more effective, patient-relevant…